BRAF V600E
Clinical trials for BRAF V600E explained in plain language.
Never miss a new study
Get alerted when new BRAF V600E trials appear
Sign up with your email to follow new studies for BRAF V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail aims to outsmart Hard-to-Treat colorectal cancer
Disease control Recruiting nowThis study tests a combination of four drugs (sintilimab, ipilimumab, cetuximab, and dabrafenib) in people with a specific type of advanced colorectal cancer that has a BRAF V600E mutation and is microsatellite stable (MSS). These cancers are hard to treat and don't respond well …
Matched conditions: BRAF V600E
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis study tests an experimental oral drug, S241656, in people with advanced cancers (like lung, colon, or pancreatic) that have certain gene changes (KRAS, BRAF, or related). The drug is taken daily in 28-day cycles, either alone or with other cancer treatments. The goal is to f…
Matched conditions: BRAF V600E
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Scientists peek inside lung tumors to outsmart drug resistance
Knowledge-focused Recruiting nowThis study looks at why some lung cancer cells survive targeted treatment. Researchers will take small tissue samples (biopsies) from 100 patients before and two weeks after starting therapy. By comparing the samples, they hope to find early signs of resistance and identify ways …
Matched conditions: BRAF V600E
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 16, 2026 22:05 UTC